Market Overview:
The global substance abuse therapeutics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of addiction, increasing awareness about available treatments, and growing demand for novel therapies. The opioid addiction segment is expected to account for the largest share of the global substance abuse therapeutics market in 2018. This segment is projected to grow at a CAGR of 8% from 2018 to 2030. The tobacco/nicotine addiction segment is projected to grow at the highest CAGR during the forecast period. This growth can be attributed to increasing awareness about the health hazards associated with smoking and nicotine consumption and rising demand for smoking cessation therapies. In terms of application, hospitals & clinics are expected to account for the largest share of the global substance abuse therapeutics market in 2018.
Product Definition:
Substance Abuse Therapeutics is the branch of pharmacology that deals with the use of drugs in the treatment of substance abuse. Substance abuse is a term used to describe the misuse of drugs or alcohol. Substance abuse can lead to addiction and other health problems.
Opioid Addiction:
Opioid addiction is a chronic disease characterized by compulsive seeking of the drug and inability to stop taking it even in the face of adverse consequences. The American Medical Association has classified opioid addiction as a distinct disorder, which is parallel to alcohol and tobacco abuse disorders.
Tobacco/Nicotine Addiction:
Tobacco/Nicotine addiction is a chronic disease with an increasing prevalence rate. It has been estimated that 1 in 13 people are addicted to tobacco and it is also considered as one of the most dangerous addictions which leads to various diseases such as cardiac disorders, lung cancer, and respiratory problems. According to the CDC, over 100 million people are affected by nicotine addiction in U.S., making it one of the most common substances of abuse among American adults other than alcohol and marijuana.
Application Insights:
Based on application, the global substance abuse therapeutics market is segmented into residential (non-hospital) and hospital & clinics. The residential (non-hospital) segment dominated the overall industry in 2017 due to factors such as increasing prevalence of drug and alcohol abuse, growing demand for treatment services among patients suffering from addiction, and an increase in government funding for rehabilitation centers.
The hospital & clinics segment is expected to grow at a significant rate over the forecast period due to factors such as increasing number of detoxification centers across the globe coupled with rising awareness about substance abuse treatments among patients admitted in hospitals for other reasons. In addition, an increase in spending capacity by governments across various regions has resulted in increased investment by private players toward establishment of new facilities offering effective treatment options.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing substance abuse cases, rising government initiatives, and increasing awareness about mental disorders. Moreover, availability of effective treatment methods and growing demand for such treatments are also driving the growth of this regional market.
Asia Pacific is estimated to be one of the fastest-growing regions during the same period owing to rapid economic development coupled with a high prevalence rate for substance abuse disorders in countries like China & India. In addition, Japan has been witnessing an increase in opioid addiction cases over last few years which is anticipated to drive regional growth over next eight years till 2030 time frame.
Europe was estimated as second largest region by revenue share in 2017 owing both parts; developed.
Growth Factors:
- Increasing prevalence of substance abuse: The number of people addicted to drugs and alcohol is increasing at an alarming rate across the globe. This is driving the demand for effective substance abuse therapies.
- Growing awareness about available treatments: There is growing awareness among people about the availability of effective treatments for substance abuse disorders. This is helping to drive demand for these therapies.
- Rising incidence of co-occurring mental disorders: A large number of people with substance abuse disorders also suffer from co-occurring mental health conditions such as depression, anxiety, and bipolar disorder. This is driving the demand for integrated treatment approaches that can address both conditions simultaneously.
- Growing focus on evidence-based therapies: There is a growing focus on evidence-based therapies for treating substance abuse disorders in order to improve outcomes and reduce relapse rates .This is helping to drive demand for these therapies . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Substance Abuse Therapeutics Market Research Report
By Type
Opioid Addiction, Tobacco/Nicotine Addiction, Alcohol Dependence
By Application
Hospital & Clinics, Residential (non-hospital)
By Companies
Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Substance Abuse Therapeutics Market Report Segments:
The global Substance Abuse Therapeutics market is segmented on the basis of:
Types
Opioid Addiction, Tobacco/Nicotine Addiction, Alcohol Dependence
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinics, Residential (non-hospital)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Indivior
- Pfizer
- Alkermes
- Novartis
- Mylan
- Cipla
- Glenmark
- Dr. Reddy's Laboratories
- Teva Pharmaceutical
Highlights of The Substance Abuse Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Opioid Addiction
- Tobacco/Nicotine Addiction
- Alcohol Dependence
- By Application:
- Hospital & Clinics
- Residential (non-hospital)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Substance Abuse Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Substance abuse therapeutics is a term used to describe the use of medications and other treatments for substance abuse. These treatments can help people who are addicted to drugs or alcohol overcome their addiction, and may also help them manage their behavior in ways that prevent them from abusing substances.
Some of the major companies in the substance abuse therapeutics market are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical.
The substance abuse therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Substance Abuse Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Substance Abuse Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Substance Abuse Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Substance Abuse Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Substance Abuse Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Substance Abuse Therapeutics Market Size and Y-o-Y Growth
4.5.2 Substance Abuse Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Substance Abuse Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Substance Abuse Therapeutics Market Size Forecast by Type
5.2.1 Opioid Addiction
5.2.2 Tobacco/Nicotine Addiction
5.2.3 Alcohol Dependence
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Substance Abuse Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Substance Abuse Therapeutics Market Size Forecast by Applications
6.2.1 Hospital & Clinics
6.2.2 Residential (non-hospital)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Substance Abuse Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Substance Abuse Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Substance Abuse Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Substance Abuse Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Substance Abuse Therapeutics Market Size Forecast by Type
9.6.1 Opioid Addiction
9.6.2 Tobacco/Nicotine Addiction
9.6.3 Alcohol Dependence
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Substance Abuse Therapeutics Market Size Forecast by Applications
9.10.1 Hospital & Clinics
9.10.2 Residential (non-hospital)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Substance Abuse Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Substance Abuse Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Substance Abuse Therapeutics Market Size Forecast by Type
10.6.1 Opioid Addiction
10.6.2 Tobacco/Nicotine Addiction
10.6.3 Alcohol Dependence
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Substance Abuse Therapeutics Market Size Forecast by Applications
10.10.1 Hospital & Clinics
10.10.2 Residential (non-hospital)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Substance Abuse Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Substance Abuse Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Substance Abuse Therapeutics Market Size Forecast by Type
11.6.1 Opioid Addiction
11.6.2 Tobacco/Nicotine Addiction
11.6.3 Alcohol Dependence
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Substance Abuse Therapeutics Market Size Forecast by Applications
11.10.1 Hospital & Clinics
11.10.2 Residential (non-hospital)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Substance Abuse Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Substance Abuse Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Substance Abuse Therapeutics Market Size Forecast by Type
12.6.1 Opioid Addiction
12.6.2 Tobacco/Nicotine Addiction
12.6.3 Alcohol Dependence
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Substance Abuse Therapeutics Market Size Forecast by Applications
12.10.1 Hospital & Clinics
12.10.2 Residential (non-hospital)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Substance Abuse Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Substance Abuse Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Substance Abuse Therapeutics Market Size Forecast by Type
13.6.1 Opioid Addiction
13.6.2 Tobacco/Nicotine Addiction
13.6.3 Alcohol Dependence
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Substance Abuse Therapeutics Market Size Forecast by Applications
13.10.1 Hospital & Clinics
13.10.2 Residential (non-hospital)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Substance Abuse Therapeutics Market: Competitive Dashboard
14.2 Global Substance Abuse Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Indivior
14.3.2 Pfizer
14.3.3 Alkermes
14.3.4 Novartis
14.3.5 Mylan
14.3.6 Cipla
14.3.7 Glenmark
14.3.8 Dr. Reddy's Laboratories
14.3.9 Teva Pharmaceutical
